Logo image of ALLIX.PA

WALLIX GROUP (ALLIX.PA) Stock Fundamental Analysis

EPA:ALLIX - Euronext Paris - Matif - FR0010131409 - Common Stock - Currency: EUR

11.94  0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALLIX. ALLIX was compared to 99 industry peers in the Software industry. ALLIX may be in some trouble as it scores bad on both profitability and health. ALLIX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALLIX has reported negative net income.
In the past year ALLIX has reported a negative cash flow from operations.
In the past 5 years ALLIX always reported negative net income.
In the past 5 years ALLIX reported 4 times negative operating cash flow.
ALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLIX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M

1.2 Ratios

Looking at the Return On Assets, with a value of -16.96%, ALLIX is doing worse than 76.77% of the companies in the same industry.
Looking at the Return On Equity, with a value of -96.25%, ALLIX is doing worse than 79.80% of the companies in the same industry.
Industry RankSector Rank
ROA -16.96%
ROE -96.25%
ROIC N/A
ROA(3y)-10.65%
ROA(5y)-11.63%
ROE(3y)-34.58%
ROE(5y)-30.79%
ROIC(3y)N/A
ROIC(5y)N/A
ALLIX.PA Yearly ROA, ROE, ROICALLIX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10 -20 -30 -40 -50

1.3 Margins

Looking at the Gross Margin, with a value of 109.63%, ALLIX belongs to the top of the industry, outperforming 96.97% of the companies in the same industry.
ALLIX's Gross Margin has been stable in the last couple of years.
ALLIX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 109.63%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.32%
GM growth 5Y-1.26%
ALLIX.PA Yearly Profit, Operating, Gross MarginsALLIX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 100

More info and screens

0

2. Health

2.1 Basic Checks

ALLIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALLIX has been increased compared to 1 year ago.
The number of shares outstanding for ALLIX has been increased compared to 5 years ago.
The debt/assets ratio for ALLIX is higher compared to a year ago.
ALLIX.PA Yearly Shares OutstandingALLIX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
ALLIX.PA Yearly Total Debt VS Total AssetsALLIX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

Based on the Altman-Z score of -0.22, we must say that ALLIX is in the distress zone and has some risk of bankruptcy.
ALLIX has a Altman-Z score of -0.22. This is in the lower half of the industry: ALLIX underperforms 75.76% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that ALLIX is somewhat dependend on debt financing.
The Debt to Equity ratio of ALLIX (0.90) is worse than 77.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACCN/A
WACC7.87%
ALLIX.PA Yearly LT Debt VS Equity VS FCFALLIX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

ALLIX has a Current Ratio of 0.90. This is a bad value and indicates that ALLIX is not financially healthy enough and could expect problems in meeting its short term obligations.
ALLIX has a Current ratio of 0.90. This is in the lower half of the industry: ALLIX underperforms 72.73% of its industry peers.
A Quick Ratio of 0.90 indicates that ALLIX may have some problems paying its short term obligations.
With a Quick ratio value of 0.90, ALLIX is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.9
ALLIX.PA Yearly Current Assets VS Current LiabilitesALLIX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

ALLIX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.57%.
Looking at the last year, ALLIX shows a quite strong growth in Revenue. The Revenue has grown by 11.73% in the last year.
Measured over the past years, ALLIX shows a quite strong growth in Revenue. The Revenue has been growing by 19.01% on average per year.
EPS 1Y (TTM)-9.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.66%
Revenue 1Y (TTM)11.73%
Revenue growth 3Y14.56%
Revenue growth 5Y19.01%
Sales Q2Q%8.67%

3.2 Future

Based on estimates for the next years, ALLIX will show a very strong growth in Earnings Per Share. The EPS will grow by 43.69% on average per year.
The Revenue is expected to grow by 20.75% on average over the next years. This is a very strong growth
EPS Next Y26.32%
EPS Next 2Y42.26%
EPS Next 3Y43.69%
EPS Next 5YN/A
Revenue Next Year13.12%
Revenue Next 2Y18.12%
Revenue Next 3Y20.75%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALLIX.PA Yearly Revenue VS EstimatesALLIX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
ALLIX.PA Yearly EPS VS EstimatesALLIX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 -0.5 1 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALLIX. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 463.69, ALLIX can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, ALLIX is valued a bit more expensive than the industry average as 67.68% of the companies are valued more cheaply.
ALLIX's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.10.
Industry RankSector Rank
PE N/A
Fwd PE 463.69
ALLIX.PA Price Earnings VS Forward Price EarningsALLIX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALLIX.PA Per share dataALLIX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALLIX does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ALLIX's earnings are expected to grow with 43.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.26%
EPS Next 3Y43.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALLIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WALLIX GROUP

EPA:ALLIX (3/7/2025, 7:00:00 PM)

11.94

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)03-20 2025-03-20/amc
Inst Owners14.85%
Inst Owner ChangeN/A
Ins Owners19.83%
Ins Owner ChangeN/A
Market Cap79.52M
Analysts84
Price Target14.28 (19.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.7%
PT rev (3m)3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.71%
Revenue NY rev (3m)-2.71%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 463.69
P/S 2.53
P/FCF N/A
P/OCF N/A
P/B 8.8
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.34
EYN/A
EPS(NY)0.03
Fwd EY0.22%
FCF(TTM)-1.4
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS4.71
BVpS1.36
TBVpS-1.5
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.96%
ROE -96.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 109.63%
FCFM N/A
ROA(3y)-10.65%
ROA(5y)-11.63%
ROE(3y)-34.58%
ROE(5y)-30.79%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.32%
GM growth 5Y-1.26%
F-Score2
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 124.6%
Cap/Sales 16.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.9
Altman-Z -0.22
F-Score2
WACC7.87%
ROIC/WACCN/A
Cap/Depr(3y)146.9%
Cap/Depr(5y)151.4%
Cap/Sales(3y)21.46%
Cap/Sales(5y)23.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-9.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-5.66%
EPS Next Y26.32%
EPS Next 2Y42.26%
EPS Next 3Y43.69%
EPS Next 5YN/A
Revenue 1Y (TTM)11.73%
Revenue growth 3Y14.56%
Revenue growth 5Y19.01%
Sales Q2Q%8.67%
Revenue Next Year13.12%
Revenue Next 2Y18.12%
Revenue Next 3Y20.75%
Revenue Next 5YN/A
EBIT growth 1Y-6.17%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.55%
EBIT Next 3Y55.72%
EBIT Next 5YN/A
FCF growth 1Y-98.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-310.3%
OCF growth 3YN/A
OCF growth 5YN/A